Tag Archives: Cannevert Therapeutics

Veritas Pharma

Veritas Announces Private Placement

Veritas Announces Private Placement

Veritas Pharma Inc. (the “Company”) (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), is pleased to announce that a non-brokered private placement offering of up to 9,090,910 units (“Units”) at a price of $0.22 per Unit for aggregate gross proceeds of up to $2,000,000 (the “Offering”).

Veritas Pharma

Veritas Reaches Important Scientific Milestone; Animal Studies Fully Underway to Evaluate the Safety and Effectiveness of Cannabis Strains

VANCOUVER, Aug. 10, 2016 /Weed Wire/ — Veritas Pharma Inc. announced the Company has initiated its crucial next phase of research and development, commencing functional pharmacological evaluations in rodents related to multiple cannabis strains.

Veritas Pharma

Veritas Pharma Embarks on Important Next Phase of Cannabis Research

VANCOUVER, Aug. 3, 2016 /Weed Wire/ — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) is pleased to announce that through Cannevert Therapeutics Ltd, Veritas’ research arm, has developed several candidate cannabis strains and is now fully engaged in chemical and biological assessment of these key strains.


Top